Who invested in Twentyeight-Seven Therapeutics?
Twentyeight-Seven Therapeutics's investors include Vertex Ventures, Sofinnova Partners and Longwood Fund.
Who invested in Twentyeight-Seven Therapeutics
One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$15Mraised across 1 round since 2019, from 1 source
- Latest round
- Series A, $15MMay 2019
- Investors
- 3
The rounds
- May 2019
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Twentyeight-Seven Therapeutics
How much has Twentyeight-Seven Therapeutics raised?
Twentyeight-Seven Therapeutics has raised $15M across 1 round since 2019.
When did Twentyeight-Seven Therapeutics last raise?
Twentyeight-Seven Therapeutics's most recent round was a Series A of $15M in May 2019.
What was Twentyeight-Seven Therapeutics's biggest round?
Its most recent round, $15M in May 2019, is also its largest on record.
Who backed Twentyeight-Seven Therapeutics first?
Twentyeight-Seven Therapeutics's first round on record, in May 2019, was backed by Vertex Ventures, Sofinnova Partners and Longwood Fund.
What stage is Twentyeight-Seven Therapeutics at?
Twentyeight-Seven Therapeutics's latest named round is a Series A, in May 2019.
Companies like Twentyeight-Seven Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.